Radiomics Signature as a Predictive Factor for EGFR Mutations in Advanced Lung Adenocarcinoma

Purpose: To develop and validate a radiomic signature to identify EGFR mutations in patients with advanced lung adenocarcinoma. Methods: This study involved 201 patients with advanced lung adenocarcinoma (140 in the training cohort and 61 in the validation cohort). A total of 396 features were extra...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Duo, Xu, Ke, Zhang, Lina, Wan, Xiaoting, Guo, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005234/
https://www.ncbi.nlm.nih.gov/pubmed/32082997
http://dx.doi.org/10.3389/fonc.2020.00028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005234/
https://www.ncbi.nlm.nih.gov/pubmed/32082997
http://dx.doi.org/10.3389/fonc.2020.00028

Ejemplares similares